Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
2/7/2013 9:54:50 AM
More...
|
Metabolic Solutions Development Company Announces Publication of Phase 2b Data in Clinical Pharmacology & Therapeutics
1/25/2013 6:00:14 AM
More...
|
Metabolic Solutions Development Company Receives $1.1 Million National Institutes of Health (NIH) Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease
10/7/2011 2:00:37 PM
More...
|
Metabolic Solutions Development Company Presents New Brown Fat Research at the European Association for the Study of Diabetes
9/13/2011 12:03:23 PM
More...
|
Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of its Second Compound to Treat Type 2 Diabetes
9/9/2011 6:44:01 AM
More...
|
Metabolic Solutions Development Company Raises Another $6.8 Million
8/16/2011 7:06:38 AM
More...
|
Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial
7/6/2011 9:05:36 AM
More...
|
Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
6/21/2011 8:43:56 AM
More...
|
Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes
3/29/2011 9:43:07 AM
More...
|
Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
5/14/2009 9:31:21 AM
More...
|
|